Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations

E. Babaoglu (ANKARA, Turkey)

Source: International Congress 2017 – COPD and weaning
Session: COPD and weaning
Session type: Thematic Poster
Number: 2097
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Babaoglu (ANKARA, Turkey). Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations. 2097

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018

LSC - 2019 - Assessment of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio as biomarkers of steroid resistance in patients with COPD
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019



Effect of CPAP therapy on neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with obstructive sleep apnea.
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017

Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of COPD.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017

Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018


Does the peripheral blood neutrophil lymphocyte ratio increase as the stage of sarcoidosis progresses?
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study>
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017

The meaning of a high monocyte to lymphocyte ratio in tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019


Immunomodulation effect on neutrophil leukocyte and lymphocyte subsets in septic rats
Source: Annual Congress 2010 - Pulmonary infections and sepsis
Year: 2010


Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype
Source: Virtual Congress 2020 – Monitoring of patients with COPD
Year: 2020


Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Neutrophil to lymphocyte ratio and severity of COPD : prospective study
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021


Stability of blood eosinophilia and neutrophil-to-lymphocyte ratio in COPD
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018



Reproducibility of COPD blood eosinophil counts
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

Definition of COPD phenotype depending on eosinophil count
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015



Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


The reproducibility of COPD blood eosinophil counts
Source: Eur Respir J, 52 (1) 1800427; 10.1183/13993003.00427-2018
Year: 2018



Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017



The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 114s
Year: 2002